You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

new therapies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

OTTAPE : Observatory on Use of New Therapies in Treatment of

Active, not recruiting
  • Pelvic-perineal Pathology
  • None. This is a non-interventional observational study.
  • Nîmes, France
    CHU Nimes
Feb 3, 2022

Identify Barriers to Cellular Therapies for People With Plasma

Recruiting
  • Multiple Myeloma
  • Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 6, 2023

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Dermatophytoses, Skin Lesion Trial in Plasencia (application of cream "La Chinata")

Recruiting
  • Dermatophytoses
  • Skin Lesion
  • application of cream "La Chinata"
  • Plasencia, Cáceres, Spain
    Raquel Mayordomo Acevedo
Mar 8, 2023

Endoscopic Bariatric Therapies: A Retrospective and Prospective

Recruiting
  • Obesity
  • +3 more
  • Endoscopic Bariatric Therapies
  • New York, New York
    Weill Cornell Medicine
Jul 27, 2022

Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab

Completed
  • Multiple Sclerosis
    • East Hanover, New Jersey
      Novartis
    Jul 14, 2023

    Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

    Recruiting
    • Hepatitis B, Chronic
    • Auckland, New Zealand
    • +1 more
    Dec 19, 2022

    Discontinuation of Disease Modifying Therapies in Multiple

    Completed
    • Multiple Sclerosis
      • Aurora, Colorado
      • +9 more
      Dec 15, 2022

      Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma:

      Completed
      • Diffuse Large B-cell Lymphoma
        • East Hanover, New Jersey
          Novartis
        Jun 16, 2023

        Biologics or Small Molecule Therapies in Inflammatory Bowel

        Completed
        • Crohn's Disease
        • Ulcerative Colitis
          • New York, New York
          • +1 more
          Jan 9, 2023

          Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer

          Recruiting
          • Ovarian Cancer
            • Albuquerque, New Mexico
              University of New Mexico Cancer Center
            Oct 4, 2022

            Learn About Novel Hormonal Therapies for Metastatic

            Not yet recruiting
            • Prostatic Neoplasms
            • Novel hormonal therapy
            • New York, New York
              Pfizer Inc
            Nov 21, 2023

            s to Learn More About Treatment With Steroidal Mineralocorticoid

            Active, not recruiting
            • Chronic Kidney Disease
            • +2 more
            • sMRA therapies
            • Whippany, New Jersey
              Many Locations
            Jan 30, 2023

            3L+ Therapies Among Chronic Myeloid Leukemia and Those With

            Completed
            • Chronic Myeloid Leukemia
              • East Hanover, New Jersey
                Novartis Investigative Site
              Nov 11, 2022

              GastroEsophageal Cancer, Gastric Cancer Trial in New York (Lenvatinib, Pembrolizumab)

              Recruiting
              • GastroEsophageal Cancer
              • Gastric Cancer
              • New York, New York
              • +1 more
              Aug 12, 2022

              Advanced NSCLC, Metastatic Lung Cancer Trial in East Syracuse, Cleveland, Bellingham (Adagrasib in combination with

              Recruiting
              • Advanced NSCLC
              • Metastatic Lung Cancer
              • Adagrasib in combination with pembrolizumab
              • Pembrolizumab
              • East Syracuse, New York
              • +2 more
              Nov 28, 2022

              Prostate Cancer Trial in New York (cryotherapy)

              Recruiting
              • Prostate Cancer
              • cryotherapy
              • New York, New York
                Weill Cornell Medicine
              Feb 23, 2022

              Opioid Use Disorder Trial in Worldwide (NIATx)

              Not yet recruiting
              • Opioid Use Disorder
              • NIATx
              • New Haven, Connecticut
              • +3 more
              Oct 10, 2022

              l Gene Editing Therapy for Cardiovascular Disease

              Not yet recruiting
              • Atherosclerotic Cardiovascular Disease
              • +2 more
                • Auckland, New Zealand
                • +2 more
                Oct 31, 2023

                De-convoluting Interactions Between Genes, Cancer Environment,

                Recruiting
                • Triple Negative Breast Cancer
                • Live Biobank
                • New York, New York
                • +1 more
                Mar 26, 2022

                Cancer Trial in New Taipei City (solid organ malignancies treatment)

                Recruiting
                • Cancer
                • solid organ malignancies treatment
                • New Taipei City, Taiwan
                  TuCheng Hospital
                May 18, 2022

                Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

                Recruiting
                • Prostate Cancer
                • Stage IV Prostate Cancer
                • Luteinizing Hormone Releasing Hormone
                • +3 more
                • Tampa, Florida
                  Moffitt Cancer Center
                Jun 1, 2022

                Solid Tumor Trial in United States (drug, combination product, biological)

                Recruiting
                • Solid Tumor
                • Pembrolizumab
                • +2 more
                • Sacramento, California
                • +6 more
                Jan 3, 2023

                Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma

                Completed
                • Diffuse Large B-cell Lymphoma (DLBCL)
                • CAR-T
                • Allo-HSCT cohort
                • East Hanover, New Jersey
                  Novartis Investigative Site
                Jun 29, 2022

                Targeted Therapies in BRAF Positive Metastatic Melanoma in US

                Active, not recruiting
                • Melanoma
                • New York, New York
                  Pfizer Investigational Site
                Feb 18, 2022